33 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... EFFECTS AND ... Medications #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... of action, side effect ... drugs. ... #pharmacology #dm2 ... #overview #management
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... of action, side effect ... anti-coagulation drugs ... anticoagulation #pharmacology ... #management #drugs
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... failure Common Side Effects ... definitively cause/effect ... #Pharmacology # ... Summary #DM2 #diabetes
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir & Cobicistat 

Ritonavir & Cobicistat are 2 pharmacokinetic boosters used
boosters used in HIV treatment ... metabolism of drugs ... both have lots of drug ... has less side effects ... HIV #Boosters #Pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... include side effects ... Side effects include ... #Pharmacology # ... Medications #DM2 #Diabetes
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
of action, side effect ... anti-inflammatory drugs ... #NSAIDS #management ... #pharmacology # ... #medications #treatment
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Agents Subclass, Drug ... Mechanism of Action, Effects ... others SGLT2 INHIBITORS ... #Medications #Pharmacology ... #summary #table
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
hypoglycemia risk and effect ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #treatment
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
titrate up to effects ... This drug class ... only few side effects ... Renal #Dosing #Pharmacology ... #Management #Diabetes